BioVersys AG (SWX:BIOV)
Switzerland · Delayed Price · Currency is CHF 27.20
+0.70 (2.64%)
At close: Sep 11, 2026
BioVersys AG Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, BioVersys AG stock has a consensus rating of "Strong Buy" and an average price target of CHF 65.05. The average 1-year stock price forecast is 139.15% higher than the current stock price, while the lowest is CHF 40.00 (+47.06%) and the highest is CHF 100.00 (+267.65%).
Price Target: CHF 65.05 (+139.15%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for BioVersys AG stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates CHF 40.00 | Buy | Reiterates | CHF 40.00 | +47.06% | Sep 11, 2026 |
| UBS | UBS | Buy Reiterates CHF 48.00 → CHF 47.00 | Buy | Reiterates | CHF 48.00 → CHF 47.00 | +72.79% | Sep 10, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Reiterates CHF 70.00 | Buy | Reiterates | CHF 70.00 | +157.35% | Mar 31, 2026 |
Financial Forecast
Revenue This Year
700.00K
from 3.18M
Decreased by -77.95%
Revenue Next Year
4.84M
from 700.00K
Increased by 591.43%
EPS This Year
-3.85
from -3.89
EPS Next Year
-5.61
from -3.85
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CHF.